Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells

Journal of Neurochemistry

Volumn 126, Issue 4, 2013, Pages 541-549

  Urrutia, Pamela ^a   Aguirre, Pabla ^a   Esparza, Andrés ^a   Tapia, Victoria ^a   Mena, Natalia P ^a   Arredondo, Miguel ^a   González Billault, Christian ^a   Núñez, Marco T ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

DMT1; FPN1; hepcidin; inflammation; iron accumulation; neurodegeneration

Indexed keywords

FERROPORTIN 1; HEPCIDIN; INTERLEUKIN 6; IRON; LIPOPOLYSACCHARIDE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; ANTIMICROBIAL CATIONIC PEPTIDE; CATION TRANSPORT PROTEIN; DMT1 PROTEIN, RAT; MESSENGER RNA; METAL TRANSPORTING PROTEIN 1;

ANIMAL CELL; ARTICLE; ASTROCYTE; BIOACCUMULATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; EMBRYO; HORMONE SYNTHESIS; INFLAMMATION; MICROGLIA; NERVE CELL; NERVE CELL LESION; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; CYTOLOGY; ENCEPHALITIS; FEMALE; FETUS; FPN1; GENETICS; IMMUNOLOGY; MALE; METABOLISM; NERVE DEGENERATION; PRIMARY CELL CULTURE; SPRAGUE DAWLEY RAT;

RATTUS;

DMT1; FPN1; HEPCIDIN; INFLAMMATION; IRON ACCUMULATION; NEURODEGENERATION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ASTROCYTES; BRAIN; CATION TRANSPORT PROTEINS; ENCEPHALITIS; FEMALE; FETUS; INTERLEUKIN-6; IRON; LIPOPOLYSACCHARIDES; MALE; MICROGLIA; NERVE DEGENERATION; NEURONS; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885953717     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12244     Document Type: Article

References (50)

1. Aguirre P., Mena N., Tapia V., Arredondo M., and, Núñez M. T., (2005) Iron homeostasis in neuronal cells: a role for IREG1. BMC Neurosci. 6, 3.
2. Aguirre P., Urrutia P., Tapia V., Villa M., Paris I., Segura-Aguilar J., and, Núñez M. T., (2012) The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1. Biometals 25, 795-803.
3. Anderson G. J., and, Vulpe C. D., (2009) Mammalian iron transport. Cell. Mol. Life Sci. 66, 3241-3261.
4. von Bernhardi R., and, Eugenin J., (2012) Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid. Redox Signal. 16, 974-1031.
5. Brasse-Lagnel C., Karim Z., Letteron P., Bekri S., Bado A., and, Beaumont C., (2011) Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Gastroenterology 140, e1261.
6. Cahill C. M., Lahiri D. K., Huang X., and, Rogers J. T., (2009) Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim. Biophys. Acta 1790, 615-628.
7. Chaston T., Chung B., Mascarenhas M., Marks J., Patel B., Srai S. K., and, Sharp P., (2008) Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut 57, 374-382.
8. Du F., Qian Z. M., Gong Q., Zhu Z. J., Lu L., and, Ke Y., (2012) The iron regulatory hormone hepcidin inhibits expression of iron release as well as iron uptake proteins in J774 cells. J. Nutr. Biochem. 23, 1694-1700.
9. Frazier M. D., Mamo L. B., Ghio A. J., and, Turi J. L., (2011) Hepcidin expression in human airway epithelial cells is regulated by interferon-gamma. Respir. Res. 12, 100.
10. Ganz T., and, Nemeth E., (2012) Hepcidin and iron homeostasis. Biochim. Biophys. Acta 1823, 1434-1443.
11. Ge X. H., Wang Q., Qian Z. M., Zhu L., Du F., Yung W. H., Yang L., and, Ke Y., (2009) The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes. J. Nutr. Biochem. 20, 860-865.
12. Gnana-Prakasam J. P., Martin P. M., Mysona B. A., Roon P., Smith S. B., and, Ganapathy V., (2008) Hepcidin expression in mouse retina and its regulation via lipopolysaccharide/Toll-like receptor-4 pathway independent of Hfe. Biochem. J. 411, 79-88.
13. Hanke M. L., and, Kielian T., (2011) Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin. Sci. (Lond.) 121, 367-387.
14. Hubert N., and, Hentze M. W., (2002) Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc. Natl Acad. Sci. USA 99, 12345-12350.
15. Hunot S., and, Hirsch E. C., (2003) Neuroinflammatory processes in Parkinson's disease. Ann. Neurol. 53 (Suppl 3), S49-S58; discussion S58-60.
16. Hunter R. L., Liu M., Choi D. Y., Cass W. A., and, Bing G., (2008) Inflammation and age-related iron accumulation in F344 rats. Curr. Aging Sci. 1, 112-121.
17. Jomova K., and, Valko M., (2011) Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr. Pharm. Des. 17, 3460-3473.
18. Kaech S., and, Banker G., (2006) Culturing hippocampal neurons. Nat. Protoc. 1, 2406-2415.
19. Kaushal V., and, Schlichter L. C., (2008) Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci. 28, 2221-2230.
20. Kruszewski M., (2003) Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat. Res. 531, 81-92.
21. Lee P., Peng H., Gelbart T., Wang L., and, Beutler E., (2005) Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl Acad. Sci. USA 102, 1906-1910.
22. Lee Y. J., Han S. B., Nam S. Y., Oh K. W., and, Hong J. T., (2010) Inflammation and Alzheimer's disease. Arch. Pharm. Res. 33, 1539-1556.
23. Li L., Holscher C., Chen B. B., Zhang Z. F., and, Liu Y. Z., (2011) Hepcidin treatment modulates the expression of divalent metal transporter-1, ceruloplasmin, and ferroportin-1 in the rat cerebral cortex and hippocampus. Biol. Trace Elem. Res. 143, 1581-1593.
24. Liu X. B., Nguyen N. B., Marquess K. D., Yang F., and, Haile D. J., (2005) Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells Mol. Dis. 35, 47-56.
25. Mena N. P., Esparza A., Tapia V., Valdes P., and, Núñez M. T., (2008) Hepcidin inhibits apical iron uptake in intestinal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G192-G198.
26. Millonig G., Ganzleben I., Peccerella T., et al,. (2012) Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). J. Biol. Chem. 287, 37472-37482.
27. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., and, Nagatsu T., (1994a) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180, 147-150.
28. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., and, Nagatsu T., (1994b) Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165, 208-210.
29. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., and, Nagatsu T., (1996) Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci. Lett. 211, 13-16.
30. Muñoz P., Humeres A., Elgueta C., Kirkwood A., Hidalgo C., and, Núñez M. T., (2011) Iron mediates N-methyl-D-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity. J. Biol. Chem. 286, 13382-13392.
31. Nemeth E., Tuttle M. S., Powelson J., Vaughn M. B., Donovan A., Ward D. M., Ganz T., and, Kaplan J., (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093.
32. Núñez M. T., Urrutia P., Mena N., Aguirre P., Tapia V., and, Salazar J., (2012) Iron toxicity in neurodegeneration. Biometals 25, 761-776.
33. Ong W. Y., and, Farooqui A. A., (2005) Iron, neuroinflammation, and Alzheimer's disease. J. Alzheimers Dis. 8, 183-200; discussion 209-115.
34. Paradkar P. N., and, Roth J. A., (2006) Post-translational and transcriptional regulation of DMT1 during P19 embryonic carcinoma cell differentiation by retinoic acid. Biochem. J. 394, 173-183.
35. Rathore K. I., Redensek A., and, David S., (2012) Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-alpha and TGF-beta1. Glia 60, 738-750.
36. Rogers J., and, Lue L. F., (2001) Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39, 333-340.
37. Saleppico S., Mazzolla R., Boelaert J. R., Puliti M., Barluzzi R., Bistoni F., and, Blasi E., (1996) Iron regulates microglial cell-mediated secretory and effector functions. Cell. Immunol. 170, 251-259.
38. Sian-Hulsmann J., Mandel S., Youdim M. B., and, Riederer P., (2011) The relevance of iron in the pathogenesis of Parkinson's disease. J. Neurochem. 118, 939-957.
39. Smith J. A., Das A., Ray S. K., and, Banik N. L., (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull. 87, 10-20.
40. Viviani B., (2006) Preparation and coculture of neurons and glial cells. Curr. Protoc. Cell Biol. Chapter 2, Unit 2.7.
41. Wajant H., and, Scheurich P., (2011) TNFR1-induced activation of the classical NF-kappaB pathway. FEBS J. 278, 862-876.
42. Wang Q., Du F., Qian Z. M., Ge X. H., Zhu L., Yung W. H., Yang L., and, Ke Y., (2008) Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. Endocrinology 149, 3920-3925.
43. Wang S. M., Fu L. J., Duan X. L., et al,. (2010) Role of hepcidin in murine brain iron metabolism. Cell. Mol. Life Sci. 67, 123-133.
44. Wang X., Garrick M. D., Yang F., Dailey L. A., Piantadosi C. A., and, Ghio A. J., (2005) TNF, IFN-gamma, and endotoxin increase expression of DMT1 in bronchial epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L24-33.
45. Williams R., Rohr A. M., Wang W. T., Choi I. Y., Lee P., Berman N. E., Lynch S. G., and, LeVine S. M., (2011) Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis. BMC Neurosci. 12, 59.
46. Wrighting D. M., and, Andrews N. C., (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108, 3204-3209.
47. Yeh K. Y., Yeh M., and, Glass J., (2004) Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G385-G394.
48. Zechel S., Huber-Wittmer K., and, von Bohlen und Halbach O., (2006) Distribution of the iron-regulating protein hepcidin in the murine central nervous system. J. Neurosci. Res. 84, 790-800.
49. Zhang X., Haaf M., Todorich B., Grosstephan E., Schieremberg H., Surguladze N., and, Connor J. R., (2005) Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 52, 199-208.
50. Zivadinov R., Weinstock-Guttman B., and, Pirko I., (2011) Iron deposition and inflammation in multiple sclerosis. Which one comes first? BMC Neurosci. 12, 60.